1. Home
  2. CLDI vs ISPC Comparison

CLDI vs ISPC Comparison

Compare CLDI & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$0.51

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

N/A

Current Price

$0.53

Market Cap

1.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLDI
ISPC
Founded
2014
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CLDI
ISPC
Price
$0.51
$0.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.4K
★ 96.1K
Earning Date
11-13-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.03
EPS
N/A
★ N/A
Revenue
$45,000.00
★ $1,928,998.00
Revenue This Year
N/A
$638.10
Revenue Next Year
N/A
$17.50
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.09
$0.55
52 Week High
$3.10
$115.00

Technical Indicators

Market Signals
Indicator
CLDI
ISPC
Relative Strength Index (RSI) 25.67 17.24
Support Level $0.37 N/A
Resistance Level $0.60 $0.96
Average True Range (ATR) 0.07 0.08
MACD -0.01 -0.01
Stochastic Oscillator 1.16 11.04

Price Performance

Historical Comparison
CLDI
ISPC

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

Share on Social Networks: